BioSpace News Archive

Altamira Therapeutics Ltd. today highlighted the publication of an article describing the rationale for and use of betahistine in the treatment of residual dizziness following standard of care physical repositioning procedures for benign paroxysmal positional vertigo (BPPV).

Scilex Holding Company announced that in anticipation of selling our commercially available products to new and current special customers, Scilex has entered into a non-exclusive distribution agreement with a well-known and highly respected distributor with over 10 years of sales excellence, Endeavor Distribution LLC.

Shineco Inc. announced that on June 18, 2024, it entered into an Investment Letter of Intent with Beijing Oriental Meitong Technology Co., Ltd. whereby Shineco intends to invest $20 million in Meitong Technology in exchange for 80% of Meitong Technology’s shares.

Ronovo Surgical announces the successful closing of its Series B financing, raising a total of $44M million from leading healthcare technology investors to accelerate the commercialization of its proprietary modular robotic system, the Carina™ Platform, in the Chinese market and set the stage for international expansion.

Avidity Biosciences, Inc. today announced it is partnering with the FSHD Society and joining the global community of patients, caregivers, and healthcare providers to raise awareness of facioscapulohumeral muscular dystrophy in support of World FSHD Day.

10x Genomics, Inc., a leader in single cell and spatial biology, announced that it has started shipping its new Xenium Prime 5K Pan-Tissue and Pathways panel.

Ascential Medical & Life Sciences, a leader in end-to-end solutions for complex medical & life science devices that provides total commercialization services from ideation to scaled manufacturing, announced the appointment of Vinod Mirchandani as Chief Technology Officer.

Cytovale® announced that the first hospital to commercially implement the company’s IntelliSep® rapid sepsis diagnostic has now screened over 5,000 patients with the test.

Tharimmune, Inc. announced today that it has entered into a securities purchase agreement for the purchase and sale of an aggregate of 659,545 shares of its common stock.

Polarean Imaging plc, a commercial-stage medical device leader in advanced Magnetic Resonance Imaging of the lungs, announces the closing of a $12.6 million oversubscribed financing via the Alternative Investment Market of the London Stock Exchange.